Lenograstim

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Lenograstim is a recombinant granulocyte colony-stimulating factor which functions as a immunostimulator.^[1]

↑ Amadori S, Suciu S, Jehn U; et al. (2005). “Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study”. Blood. 106 (1): 27–34. doi:10.1182/blood-2004-09-3728. PMID 15761020.